Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine.
2020 Feb 06
Journal Article
Authors:
Anderson, E.J.;
Lai, L.;
Wrammert, J.;
Kabbani, S.;
Xu, Y.;
Priyamvada, L.;
Hill, H.;
Goll, J.B.;
Jensen, T.L.;
Kao, C.;
Yildirim, I.;
Rouphael, N.;
Jackson, L.;
Mulligan, M.J.
Secondary:
Vaccines (Basel)
Volume:
8
Issue:
1
PMID:
32041104
Abstract:
Background Vaccinia is known to induce antibody and cellular responses. Plasmablast, circulating follicular helper T (cT) cells, cytokine-expressing CD4 T cells, and memory B cells were compared between subcutaneous (SC) and needle-free jet injection (JI) recipients of non-replicating modified vaccinia Ankara (MVA) vaccine. Methods Vaccinia-naïve adults received MVA SC or by JI on Days 1 and 29. Vaccinia-specific antibodies were quantified by plaque reduction neutralization test (PRNT) and enzyme-linked immunosorbent assay. Plasmablast, cT, and cytokine-expressing CD4 T cells were assessed on Days 1, 8, 15, 29, 36, 43 (cT and CD4+ only) and 57. Memory B cells were measured on Days 1 and 57. Results Of the 36 enrolled subjects, only 22 received both vaccinations and had evaluable specimens after the second vaccine. Plasmablasts peaked one week after each vaccine. Day 15 plasmablasts correlated with peak PRNT titers. cT peaked on Days 8 and 36 and correlated with Day 36 plasmablasts. CD4+ peaked at Day 29 and one-third produced ≥2 cytokines. Day 57 memory B cells ranged from 0.1% to 0.17% of IgG-secreting B cells. Conclusions This study provides insights into the cellular responses to non-replicating MVA, currently used as a vector for a variety of novel vaccines.
